皮质类固醇注射治疗膝骨关节炎的最佳麻醉剂 (Injections)
皮质类固醇注射治疗膝骨关节炎的最佳麻醉剂。
To evaluate pain relief from corticosteroid injection with and without anesthetic as well as with variable volume of anesthetic. Pain relief will be measured using the VAS pain score at the time of the injection as well as several time points following the injection to capture pain relief longevity. The investigators intend to evaluate how well the patients tolerate corticosteroid mixtures without anesthetic as well as with different volumes of anesthetic. Primary measure will be the time from procedure when postoperative status is considered success (as measured by global perceived improvement score).
研究概览
详细说明
Primary objective is to evaluate pain relief from corticosteroids, Kenalog without anesthetic as well as with different volumes of anesthetic. The investigators will measure the VAS pain score at the time of the injection as well as several time points following the injection. Additionally, the investigators will evaluate how long the injection provided pain relief for the patient.
The secondary intend is to evaluate how well the patients tolerate Kenalog mixtures without anesthetic as well as with different volumes of anesthetic by using the VAS pain scale.
The investigators hypothesize that patient with lower volume of injection will experience less pain during the procedure and that there will be no statistically significant difference in pain level between the study groups during the study period.
研究类型
注册 (实际的)
阶段
- 阶段1
联系人和位置
学习地点
-
-
Florida
-
Tampa、Florida、美国、33637
- Florida Orthopaedic Institute
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Patients must be 18 years of age and be able to consent for themselves.
- OA grade Kellgren Lawrence Stage II or III.
- Diagnosis of primary osteoarthritis.
Exclusion Criteria:
- Patients with other forms of arthritis such as inflammatory arthritis.
- History of narcotic use for the past 6 months.
- Kellgren Lawrence arthritis grade 1 or 4.
- Pregnant women and prisoners.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Kenalog with 0ml bupivacaine
The intervention in this study is one intra-articular knee injection of synthetic corticosteroid (kenalog) and variable amount of anesthetic,0ml of bupivacaine. The patients will be randomized into this group. |
Indications, relevant for this study include Kenalog injection for knee pain from osteoarthritis or inflammatory arthritis. A single injection to a patient who has no known allergies to anesthetic or corticosteroids would be administered during a scheduled clinical visit.
其他名称:
|
|
实验性的:Kenalog with 4ml bupivacaine
The intervention in this study is one intra-articular knee injection of synthetic corticosteroid (kenalog) and variable amount of anesthetic,4ml of bupivacaine. The patients will be randomized into this group. |
Indications, relevant for this study include Kenalog injection for knee pain from osteoarthritis or inflammatory arthritis. A single injection to a patient who has no known allergies to anesthetic or corticosteroids would be administered during a scheduled clinical visit.
其他名称:
|
|
实验性的:Kenalog with 0.25% bupivacaine
The intervention in this study is one intra-articular knee injection of synthetic corticosteroid (kenalog) and variable amount of anesthetic,0.25% of bupivacaine. The patients will be randomized into this group. |
Indications, relevant for this study include Kenalog injection for knee pain from osteoarthritis or inflammatory arthritis. A single injection to a patient who has no known allergies to anesthetic or corticosteroids would be administered during a scheduled clinical visit.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Injection for Knee Pain
大体时间:Prior to procedure (in office)
|
Visual Analogue Scale (VAS) |
Prior to procedure (in office)
|
|
Injection for Knee Pain
大体时间:Immediate post procedure (in office)
|
Visual Analogue Scale (VAS) |
Immediate post procedure (in office)
|
|
Injection for Knee Pain
大体时间:2 minutes post procedure (in office)
|
Visual Analogue Scale (VAS) |
2 minutes post procedure (in office)
|
|
Injection for Knee Pain
大体时间:Day 1 post procedure (phone interview)
|
Visual Analogue Scale (VAS) |
Day 1 post procedure (phone interview)
|
|
Injection for Knee Pain
大体时间:Day 14 post procedure (through EDC)
|
Visual Analogue Scale (VAS) |
Day 14 post procedure (through EDC)
|
|
Injection for Knee Pain
大体时间:Day 42 post procedure (in office)
|
Visual Analogue Scale (VAS) |
Day 42 post procedure (in office)
|
|
Injection for Knee Pain
大体时间:Day 84 post procedure (through EDC)
|
Visual Analogue Scale (VAS) |
Day 84 post procedure (through EDC)
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Assessment of Knee Pain
大体时间:Immediate Post-op (in office)
|
Global Perceived Improvement |
Immediate Post-op (in office)
|
|
Assessment of Knee Pain
大体时间:Day 1 post procedure (phone interview)
|
Global Perceived Improvement |
Day 1 post procedure (phone interview)
|
|
Assessment of Knee Pain
大体时间:Day 42 post procedure (in office)
|
Global Perceived Improvement |
Day 42 post procedure (in office)
|
|
Assessment of Knee Pain
大体时间:Day 84 post procedure (through EDC)
|
Global Perceived Improvement |
Day 84 post procedure (through EDC)
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Medications
大体时间:Prior to procedure (in office)
|
Review of Medications |
Prior to procedure (in office)
|
|
Medications
大体时间:Day 1 post procedure (phone interview)
|
Review of Medications |
Day 1 post procedure (phone interview)
|
|
Medications
大体时间:Day 14 post procedure (through EDC)
|
Review of Medications |
Day 14 post procedure (through EDC)
|
|
Medications
大体时间:Day 42 post procedure (in office)
|
Review of Medications |
Day 42 post procedure (in office)
|
|
Medications
大体时间:Day 84 post procedure (through EDC)
|
Review of Medications |
Day 84 post procedure (through EDC)
|
|
Review of Adverse Events
大体时间:Immediate post procedure (in office)
|
Any issues with procedure |
Immediate post procedure (in office)
|
|
Review of Adverse Events
大体时间:Day 1 post procedure (phone interview)
|
Any issues with procedure |
Day 1 post procedure (phone interview)
|
|
Review of Adverse Events
大体时间:Day 42 post procedure (in office)
|
Any issues with procedure |
Day 42 post procedure (in office)
|
|
Review of Adverse Events
大体时间:Day 84 post procedure (through EDC)
|
Any issues with procedure |
Day 84 post procedure (through EDC)
|
合作者和调查者
出版物和有用的链接
一般刊物
- Bedard NA, Dowdle SB, Anthony CA, DeMik DE, McHugh MA, Bozic KJ, Callaghan JJ. Response to Letter to the Editor on "The AAHKS Clinical Research Award: What Are the Costs of Knee Osteoarthritis in the Year Prior to Total Knee Arthroplasty?". J Arthroplasty. 2018 Jan;33(1):307. doi: 10.1016/j.arth.2017.10.002. Epub 2017 Oct 10. No abstract available.
- Blankstein M, Lentine B, Nelms NJ. Common Practices in Intra-Articular Corticosteroid Injection for the Treatment of Knee Osteoarthritis: A Survey of the American Association of Hip and Knee Surgeons Membership. J Arthroplasty. 2021 Mar;36(3):845-850. doi: 10.1016/j.arth.2020.09.022. Epub 2020 Oct 8.
- Grishko V, Xu M, Wilson G, Pearsall AW 4th. Apoptosis and mitochondrial dysfunction in human chondrocytes following exposure to lidocaine, bupivacaine, and ropivacaine. J Bone Joint Surg Am. 2010 Mar;92(3):609-18. doi: 10.2106/JBJS.H.01847.
- Smith MD, Wetherall M, Darby T, Esterman A, Slavotinek J, Roberts-Thomson P, Coleman M, Ahern MJ. A randomized placebo-controlled trial of arthroscopic lavage versus lavage plus intra-articular corticosteroids in the management of symptomatic osteoarthritis of the knee. Rheumatology (Oxford). 2003 Dec;42(12):1477-85. doi: 10.1093/rheumatology/keg398. Epub 2003 Jul 16.
- Parker RD, Streem K, Schmitz L, Martineau PA; Marguerite Group. Efficacy of continuous intra-articular bupivacaine infusion for postoperative analgesia after anterior cruciate ligament reconstruction: a double-blinded, placebo-controlled, prospective, and randomized study. Am J Sports Med. 2007 Apr;35(4):531-6. doi: 10.1177/0363546506296313. Epub 2007 Jan 23.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.